Cargando…

Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions

BACKGROUND: Hepatocellular carcinoma (HCC) has a poor prognosis and has become the sixth most common malignancy worldwide due to its high incidence. Advanced approaches to therapy, including immunotherapeutic strategies, have played crucial roles in decreasing recurrence rates and improving clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Qiuxian, Yang, Qin, Zhou, Jiaming, Gu, Xinyu, Zhou, Haibo, Dong, Xuejun, Zhu, Haihong, Chen, Zhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243542/ https://www.ncbi.nlm.nih.gov/pubmed/34193146 http://dx.doi.org/10.1186/s12935-021-02033-4

Ejemplares similares

Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinoma
por: Xue, Chen, et al.
Publicado: (2021)

Transcription factor E2F4 is an indicator of poor prognosis and is related to immune infiltration in hepatocellular carcinoma
por: Zheng, Qiuxian, et al.
Publicado: (2021)

Uncovering the Association Between m(5)C Regulator-Mediated Methylation Modification Patterns and Tumour Microenvironment Infiltration Characteristics in Hepatocellular Carcinoma
por: Gu, Xinyu, et al.
Publicado: (2021)

A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma
por: Ouyang, Guoqing, et al.
Publicado: (2020)

Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma
por: Hu, Yinan, et al.
Publicado: (2022)

Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes
por: Gu, Xinyu, et al.
Publicado: (2021)

Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma
por: Cai, Xiaopeng, et al.
Publicado: (2021)

Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation
por: Lin, Xia-Hui, et al.
Publicado: (2023)

An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients
por: Zhu, Gongmin, et al.
Publicado: (2021)

A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma
por: Bu, Xiaoyun, et al.
Publicado: (2022)

A novel tumor doubling time-related immune gene signature for prognosis prediction in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2021)

Phosphoribosyl Pyrophosphate Amido Transferase: A New Prognostic Biomarker for Hepatocellular Carcinoma
por: Chu, Qingfei, et al.
Publicado: (2022)

Random-forest algorithm based biomarkers in predicting prognosis in the patients with hepatocellular carcinoma
por: Guo, Lingyun, et al.
Publicado: (2020)

Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
por: Zhou, Cankun, et al.
Publicado: (2020)

Prognostic signature composed of transcription factors accurately predicts the prognosis of gastric cancer patients
por: Zhou, Liqiang, et al.
Publicado: (2021)

Identification of autophagy-related risk signatures for the prognosis, diagnosis, and targeted therapy in cervical cancer
por: Meng, Dan, et al.
Publicado: (2021)

Identification and development of a novel invasion-related gene signature for prognosis prediction in colon adenocarcinoma
por: Liu, Jiahua, et al.
Publicado: (2021)

New insights into long noncoding RNAs and pseudogenes in prognosis of renal cell carcinoma
por: Chen, Binghai, et al.
Publicado: (2018)

Identifying a ten-microRNA signature as a superior prognosis biomarker in colon adenocarcinoma
por: Ma, Rong, et al.
Publicado: (2019)

Development and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma
por: Xing, Xiao-Liang, et al.
Publicado: (2021)

Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

hERG1 channel expression associates with molecular subtypes and prognosis in breast cancer
por: Iorio, Jessica, et al.
Publicado: (2018)

Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma
por: Peng, Yanan, et al.
Publicado: (2021)

High CTHRC1 expression may be closely associated with angiogenesis and indicates poor prognosis in lung adenocarcinoma patients
por: Chen, Yangshan, et al.
Publicado: (2019)

Identification of a 6-gene signature predicting prognosis for colorectal cancer
por: Zuo, Shuguang, et al.
Publicado: (2019)

Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma
por: Shi, Jinyuan, et al.
Publicado: (2021)

Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma
por: Qin, Yuan, et al.
Publicado: (2022)

A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration
por: Luan, Jiao-chen, et al.
Publicado: (2021)

Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma
por: Liu, Gao-Min, et al.
Publicado: (2019)

BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma
por: Li, Yibing, et al.
Publicado: (2020)

PGM5 is a promising biomarker and may predict the prognosis of colorectal cancer patients
por: Sun, Yifan, et al.
Publicado: (2019)

DSG2 expression is correlated with poor prognosis and promotes early-stage cervical cancer
por: Qin, Shuhang, et al.
Publicado: (2020)

Serum-derived three-circRNA signature as a diagnostic biomarker for hepatocellular carcinoma
por: Sun, Xiang-Hong, et al.
Publicado: (2020)

Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma
por: She, Yangyang, et al.
Publicado: (2020)

Expression of the Wnt ligands gene family and its relationship to prognosis in hepatocellular carcinoma
por: Dong, Jia-Jia, et al.
Publicado: (2019)

UBE2I promotes metastasis and correlates with poor prognosis in hepatocellular carcinoma
por: Yang, Hao, et al.
Publicado: (2020)

Multilevel regulation of RUVBL2 expression predicts poor prognosis in hepatocellular carcinoma
por: Yan, Tao, et al.
Publicado: (2019)

Small nucleolar RNAs signature (SNORS) identified clinical outcome and prognosis of bladder cancer (BLCA)
por: Cao, Rui, et al.
Publicado: (2020)

Identification of a tumor microenvironment-related gene signature to improve the prediction of cervical cancer prognosis
por: Chen, Qian, et al.
Publicado: (2021)

Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_65t9chu25pg6ee65nv45790qha